Blood Thinner Medication Bleeding Treatment
Treatment for bleeding from anticoagulant includes withholding doses of anticoagulant, and the administration of fresh frozen plasma or prothrombin complex concentrate (PCC). Withholding the anticoagulant reduces the effects of the medication, while fresh frozen plasma and PCC supplies the body with chemicals that promote blood clotting. Vitamin K helps reverse the effects of warfarin (Coumadin) and protamine reverses the effects of heparin.
Treatment for minor bleeding from anticoagulant includes:
- Apply direct pressure to control bleeding:
- Maintaining constant pressure for at least 10 minutes
- Applying a dressing to the wound
Additional treatment for severe bleeding from anticoagulant may include:
Blood Thinner Medication Bleeding Questions For Doctor
The following are some important questions to ask before and after the treatment of bleeding from anticoagulant.
Questions to ask before treatment:
- What are my treatment options?
- Is surgery an option for me?
- What are the risks associated with treatment?
- Do I need to stay in the hospital?
- How long will I be in the hospital?
- What are the complications I should watch for?
- How long will I be on medication?
- What are the potential side effects of my medication?
- Does my medication interact with nonprescription medicines or supplements?
- Should I take my medication with food?
Questions to ask after treatment:
- Do I need to change my diet?
- Do I need to lose weight?
- Are there any medications or supplements I should avoid?
- When can I resume my normal activities?
- When can I return to work?
- What else can I do to reduce my risk for having this problem again?
- How often will I need to see my doctor for checkups?
- What local support and other resources are available?
Continue to Blood Thinner Medication Bleeding Home Care
- Frey D, Rahman A. Medication management: an evidence-based model that decreases adverse events. Home Healthc Nurse. 2003 Jun;21(6):404-12. 
- Gaylor DW, Bolger PM, Schwetz BA. U.S. Food and Drug Administration perspective of the inclusion of effects of low-level exposures in safety and risk assessment. Environ Health Perspect. 1998 Feb;106 Suppl 1:391-4. 
- Greer IA. Anticoagulants in pregnancy. J Thromb Thrombolysis. 2006 Feb;21(1):57-65. 
- Levine MN, Raskob G, Beyth RJ, Kearon C, Schulman S. Hemorrhagic complications of anticoagulant treatment: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3 Suppl):287S-310S. 
- Runciman WB, Roughead EE, Semple SJ, Adams RJ. Adverse drug events and medication errors in Australia. Int J Qual Health Care. 2003 Dec;15 Suppl 1:i49-59. 
- Staresinic AG, Sorkness CA, Goodman BM, Pigarelli DW. Comparison of outcomes using 2 delivery models of anticoagulation care. Arch Intern Med. 2006 May 8;166(9):997-1002.